REDCURE registry for anemia in chronic kidney disease
Part of Blood & lymphatic, Kidney & urinary clinical trials.
This study looks at how well Daprodustat works for anemia in people with chronic kidney disease, including those on dialysis or after a kidney transplant. It collects real-world data to help doctors manage this condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have chronic kidney disease (CKD) at stage 3, 4, or 5, which means your kidneys are moderately to severely damaged.
- You have anemia (low red blood cells) caused by your kidney disease.
- You are currently taking or starting the medication Daprodustat for your anemia.
- You are on hemodialysis or peritoneal dialysis, or have had a kidney transplant.
- You are able to give informed consent.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests two medicines (daprodustat and epoetin alfa) to see which one works better for treating low red blood cell counts (anemia) in people with chronic kidney disease who are not on dialysis yet. Both medicines aim to increase hemoglobin and reduce fatigue.
This trial tests a new oral medication (QLG1218, also called daprodustat) to treat anemia in people with chronic kidney disease who are on hemodialysis. It is comparing the new drug to the usual injected ESA medicines to see if it works as well or better.
This trial tests enarodustat, a pill for anemia, in people with chronic kidney disease who are not on dialysis. It aims to see if it can safely raise hemoglobin levels.
This study tracks the real-world safety of desidustat in adults with anemia caused by chronic kidney disease (CKD). It’s meant to see whether the medicine is safe when used in everyday care, not just in tightly controlled settings.
This trial tests whether roxadustat can improve kidney oxygen levels and anemia in people with diabetic kidney disease. It may help if you have anemia from kidney problems and are being considered for medicines like erythropoietin (EPO).
This study tests a daily pill that helps people with chronic kidney disease and anemia make more red blood cells, which may reduce the need for other anemia treatments. It is for patients who are not on dialysis and do not plan to start dialysis or have a kidney transplant within the next six months.
Hear when a new CKD Anemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.